KRAS and cancer: When RAS signaling is inhibited, cancer cells can escape dependency on KRAS through compensatory mechanisms involving activation of the transcriptional coactivators YAP (Yes-associated protein) and TAZ (transcriptional coactivator with PDZ-binding motif).